Immediate Impact
1 from Science/Nature 23 standout
Citing Papers
Liquid biopsy in cancer: current status, challenges and future prospects
2024 Standout
Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements
2024 Standout
Works of Daniéla Rusu being referenced
Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial
2018
Clinical and Survival Impact of FDG PET in Patients with Suspicion of Recurrent Ovarian Cancer: A 6-Year Follow-Up
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Daniéla Rusu | 67 | 79 | 79 | 99 | 15 | 198 | |
| Yeo Koon Kim | 29 | 178 | 73 | 192 | 20 | 268 | |
| Steven Nissen | 23 | 105 | 50 | 27 | 20 | 267 | |
| Susanne Kohlfürst | 83 | 69 | 138 | 126 | 11 | 274 | |
| Alexis Vrachimis | 48 | 31 | 82 | 119 | 13 | 192 | |
| Sol S. Klioze | 137 | 40 | 12 | 107 | 12 | 261 | |
| Samaneh Motanagh | 68 | 29 | 23 | 30 | 15 | 137 | |
| Isaac Cranshaw | 82 | 154 | 16 | 136 | 15 | 285 | |
| Efstratios Karagiannis | 68 | 43 | 76 | 42 | 16 | 222 | |
| Paul Sibley | 52 | 22 | 20 | 24 | 11 | 174 | |
| Gerald Minkowitz | 84 | 56 | 18 | 38 | 10 | 161 |
All Works
Loading papers...